Idexx Laboratories (IDXX) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $274.6 million.
- Idexx Laboratories' Income towards Parent Company rose 1793.89% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1860.76%. This contributed to the annual value of $887.9 million for FY2024, which is 506.78% up from last year.
- According to the latest figures from Q3 2025, Idexx Laboratories' Income towards Parent Company is $274.6 million, which was up 1793.89% from $294.0 million recorded in Q2 2025.
- In the past 5 years, Idexx Laboratories' Income towards Parent Company registered a high of $294.0 million during Q2 2025, and its lowest value of $132.0 million during Q2 2022.
- In the last 5 years, Idexx Laboratories' Income towards Parent Company had a median value of $203.5 million in 2021 and averaged $208.8 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first surged by 8259.7% in 2021, then crashed by 3461.3% in 2022.
- Idexx Laboratories' Income towards Parent Company (Quarter) stood at $162.8 million in 2021, then increased by 5.8% to $172.2 million in 2022, then grew by 12.96% to $194.5 million in 2023, then increased by 11.12% to $216.1 million in 2024, then increased by 27.05% to $274.6 million in 2025.
- Its Income towards Parent Company was $274.6 million in Q3 2025, compared to $294.0 million in Q2 2025 and $242.7 million in Q1 2025.